← Open Payments lookup

CHEQUALEIS SARGENT: Open Payments

NPI 1871007930 · MILWAUKEE, WI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$690 in 35 payments from 13 companies in 2025. Trend: 2023 $26 · 2024 $565 · 2025 $690

Food & beverage: $690
CompanyPaymentsAmount
Otsuka America Pharmaceutical, Inc.10$181
E.R. Squibb & Sons, L.L.C.4$93
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)4$72
Lundbeck LLC3$64
Janssen Pharmaceuticals, Inc3$61
Indivior Inc.2$50
Alkermes, Inc.2$46
Teva Pharmaceuticals USA, Inc.2$33
Dexcom, Inc.1$23
Gilead Sciences, Inc.1$22

Products named: REXULTI, COBENFY, CAPLYTA, ABILIFY ASIMTUFII, ABILIFY MAINTENA, SUBLOCADE, INVEGA SUSTENNA, ARISTADA.

Industry payments across WI — which companies pay providers there.